Clinical Trials Browser

Phase 1/2 × Uterine Cervical Neoplasms × Alendronate × Clear all

NCT07245381 2025-11-24

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms